What is the appropriate management for a 25-year-old female with dengue (NS1 and IgM positive, IgG negative) presenting with hypotension, severe anemia (hemoglobin 6.8 g/dL) and low hematocrit (19 %)?

Management of Severe Dengue with Hypotension and Severe Anemia

This patient requires immediate aggressive fluid resuscitation with crystalloids as the priority, followed by cautious blood transfusion for severe anemia, while carefully monitoring for fluid overload—this is dengue shock syndrome (DSS) complicated by severe anemia that demands ICU-level care.

Immediate Resuscitation (First 3 Hours)

The hypotension indicates dengue shock syndrome, which is a medical emergency requiring immediate treatment 1. The Surviving Sepsis Campaign guidelines, while designed for sepsis, provide the framework for managing shock states:

• Administer at least 30 mL/kg IV crystalloid fluid within the first 3 hours 1

  • For a 25-year-old female (assuming ~50-60 kg), this means 1500-1800 mL rapidly
  • Use normal saline or Ringer's lactate
  • Reassess hemodynamic status frequently after each bolus

• Target mean arterial pressure (MAP) ≥ 65 mmHg 1

  • Monitor blood pressure, heart rate, urine output, capillary refill
  • Assess for signs of fluid overload (respiratory distress, pulmonary edema)

Critical Diagnostic Considerations

The serologic profile (NS1+, IgM+, IgG-) indicates primary dengue infection in the acute phase 2, 3. However, the severe anemia (Hb 6.8 g/dL, Hct 19%) is NOT typical of dengue hemorrhagic fever alone and requires investigation:

Rule Out Hemolysis

This degree of anemia with dengue raises concern for:

• Intravascular hemolysis (check: indirect bilirubin, LDH, reticulocyte count, direct antiglobulin test, peripheral smear) 4, 5, 6, 7
• G6PD deficiency-triggered hemolysis 5
• Autoimmune hemolytic anemia (AIHA) triggered by dengue 6, 7
• Hemophagocytic lymphohistiocytosis (HLH) if fever persists with worsening cytopenias 4

Look for: dark urine (hemoglobinuria), jaundice, elevated indirect bilirubin, elevated LDH, low haptoglobin.

Assess for Ongoing Bleeding

• Check for active bleeding sites (GI, vaginal, epistaxis, gingival)
• Coagulation profile (PT, aPTT, fibrinogen)
• Signs of DIC if severe bleeding present

Blood Transfusion Decision

The severe anemia (Hb 6.8 g/dL) in a hypotensive patient requires blood transfusion, but with critical caveats:

• Transfuse packed red blood cells (PRBCs) cautiously to improve oxygen-carrying capacity

  • Target Hb 7-8 g/dL initially (not full correction)
  • Give slowly (over 3-4 hours per unit) to avoid volume overload
  • Monitor closely for pulmonary edema, especially during/after plasma leakage phase

• Avoid prophylactic platelet or FFP transfusion unless active severe bleeding 8

  • Prophylactic transfusion increases hospitalization length and pulmonary edema risk 8
  • Reserve for clinically significant bleeding with coagulopathy

Ongoing Monitoring and Management

Fluid Management Balance

This is the most critical aspect—dengue causes plasma leakage while the patient needs volume for shock AND blood transfusion:

• Monitor hematocrit every 4-6 hours

  • Rising Hct suggests hemoconcentration/plasma leakage (reduce crystalloid rate)
  • Falling Hct suggests bleeding or hemolysis (investigate and treat cause)

• Watch for third spacing/pleural effusions

  • Chest X-ray if respiratory distress develops
  • Ultrasound for ascites/pleural effusion

• Urine output target ≥ 0.5 mL/kg/hr

If Hemolysis Confirmed

• Consider corticosteroids (methylprednisolone 1-2 mg/kg/day) if AIHA or HLH diagnosed 4, 6, 7

  • Balance risk of corticosteroids in viral infection against life-threatening hemolysis
  • Dexamethasone 10 mg/m²/day if HLH criteria met 4

• Check ferritin, triglycerides, fibrinogen if persistent fever beyond critical phase to evaluate for HLH 4

  • Ferritin >10,000 ng/mL highly suggestive
  • Bone marrow aspirate if HLH suspected

Vasopressor Support

• If hypotension persists despite adequate fluid resuscitation, initiate vasopressors (norepinephrine preferred)
• Target MAP ≥ 65 mmHg 1

Common Pitfalls to Avoid

1. Over-resuscitation with fluids: Dengue patients are prone to pulmonary edema and pleural effusions—stop aggressive fluids once shock resolves
2. Prophylactic blood product transfusion: Increases complications without benefit 8
3. Missing hemolysis: Severe anemia in dengue should trigger hemolysis workup 4, 5, 6, 7
4. Delayed recognition of HLH: Persistent fever, worsening cytopenias, and hepatitis beyond day 5-7 warrant HLH evaluation 4

Summary Algorithm

1. Immediate: 30 mL/kg crystalloid over 3 hours + frequent reassessment
2. Concurrent: Transfuse PRBCs slowly (target Hb 7-8 g/dL)
3. Investigate: Hemolysis workup (bilirubin, LDH, DAT, peripheral smear, G6PD)
4. Monitor: Hct q4-6h, urine output, respiratory status, bleeding
5. Adjust: Reduce fluids when shock resolves; add vasopressors if refractory hypotension
6. Escalate: Consider corticosteroids if AIHA/HLH confirmed; ICU admission mandatory